American Lung Association Expands Research Grants; Opens Call for Research Applications

Organization opens application process for 2025-2026 awards and grants funding

The American Lung Association Research Institute is seeking applications for its 2025-2026 Research Awards and Grants cycle, supporting the next generation of scientists, and accelerating transformative discoveries to prevent, detect and treat lung disease. This year, the Lung Association has expanded its research opportunities with two new awards: a grant supporting research on the impact of indoor air quality on lung health, and a joint research award in partnership with the American Thoracic Society to commemorate the Lung Association’s 120th Anniversary.

The American Lung Association Research Institute funds basic, translational and clinical research, empowering promising scientists and expanding industry collaboration with the goals of eliminating lung disease and improving life for those living with lung disease.

“For 120 years, the American Lung Association has championed scientific innovation with our vision at the forefront, to create a world free of lung disease,” said American Lung Association President and CEO Harold Wimmer. "We invite scientists to apply to become a part of our impactful research team. Lung Association-funded researchers have achieved major milestones in the last century, including ending the devastation of tuberculosis in this country, saving the lives of premature babies with respiratory distress syndrome (RDS), significantly contributing to lung cancer research including biomarker testing and development of personalized therapies, launching asthma and chronic obstructive pulmonary disease (COPD) clinical research, and supporting research on SARS-CoV-2 and other respiratory viruses with pandemic potential.”

Projects funded by the Lung Association Research Institute are carefully evaluated and selected through rigorous scientific peer review. Awardees investigate a wide range of complex issues with the goal of reducing the burden of lung disease.

The 2025-2026 research funding cycle includes two new grant opportunities:

  • The Indoor Air Research Award—$100,000/year for independent researchers and $50,000/year for mentored researchers; up to three years for each award (letter of intent required). The awards seek to support researchers and scientists to generate knowledge that can inform public policies and interventions and promote healthier indoor environments.
  • The American Thoracic Society/American Lung Association/ Commemorative 120th Anniversary Joint Research Award—$60,000/year for up to two years. The award is a partnership with the American Thoracic Society for investigators aiming to improve our understanding of lung disease, either through relevant basic/translational science or outstanding clinical science research. More information on how to apply for this grant is available here.

In addition to the new grants, 2025-2026 funding opportunities include:

  • Lung Cancer Discovery Award—$100,000/year up to two years (letter of intent required). The award is for independent investigators conducting clinical, laboratory, epidemiological or any groundbreaking project aimed at revolutionizing our understanding of lung cancer and improving diagnostic, clinical and treatment methods.
  • Emerging Respiratory Pathogen Award—$100,000/year, up to two years (letter of intent required). This award was created to gain a better understanding of the pathobiology and the long term and immediate implications of respiratory infections. This includes emerging problems in known organisms and new and emerging pathogens.
  • Innovation Award—$75,000/year, up to two years. The award is for independent investigators conducting basic science, behavioral, clinical, or translational research in lung health or disease. Must have held an NIH (National Institutes of Health) K- or R-type award within five years prior, but not more than two R01 type grants.
  • Hastings Innovation Award for Interstitial Lung Disease—$75,000/year, up to two years. The award is for independent investigators conducting basic, clinical, or translational research in interstitial lung disease. Must have held a NIH K- or R-type award within five years prior to applying, but not more than two R01 type grants.
  • Allergic Respiratory Diseases Research Award—$75,000/year, up to two years. Jointly funded with the American Academy of Allergy, Asthma & Immunology (AAAAI), the award supports allergic respiratory research by investigators with a primary faculty appointment in an allergy-immunology division.
  • Catalyst Award—$50,000/year, up to two years. The award supports mentored early career scientists ascending toward independence. This award supports junior investigators conducting basic science, behavioral, clinical, or translational research into lung health and disease.
  • Dalsemer Interstitial Lung Disease Award—$50,000/year, up to two years. The award is for mentored early career scientists ascending toward independence. This award provides seed monies to junior investigators for researching the mechanisms and biology of interstitial lung disease.
  • Public Health and Public Policy Research Award—$50,000/year, up to two years. The award is designed to stimulate and inform important public policy debates around healthy air and lung disease. The intent is to support research on and evaluation of existing public policy and public health programs, and pilot new ideas in these areas.

For the 2025-2026 Lung Association Research Institute grant cycle, qualified researchers must be conducting research in the U.S. and meet individual grant qualifications and other terms and conditions. Application materials are available through proposalCENTRAL. The entire process takes 6 to 8 months and research grant awardees will be notified in June 2025. For more information, visit Lung.org/Research. 

For more information, contact:

Jill Dale
312-940-7001
[email protected]

Freedom From Smoking Clinic - Parma, OH
Parma, OH | Aug 20, 2024
Freedom From Smoking Clinic - Cleveland, OH
Cleveland, OH | Sep 25, 2024